Analytical Data
-
Gene name
Oncomodulin-1
-
简介
Oncomodulin-1 protein, exhibiting calmodulin-like activity, activates enzymes and regulates growth, binding two calcium ions and participating in calcium-mediated cellular processes. Oncomodulin-1 Protein, Human (His) is the recombinant human-derived Oncomodulin-1 protein, expressed by E. coli , with N-6*His labeled tag.
- Application
-
Alternative Names
Oncomodulin-1; OM; Parvalbumin Beta; OCM; OCM1; OCMN
-
Species
Human
-
Source
E. coli
-
Tag
N-6*His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P0CE72
-
Expression Region
M1-S109
-
Protein Length
Full Length
-
Molecular Weight
16.0 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Oncomodulin-1 (OCM-1) is a calcium-binding protein closely related to the S100 protein family, known for its involvement in various cellular processes, including cell growth, differentiation, and apoptosis. Initially discovered in tumor tissues, OCM-1 has garnered attention due to its potential roles in cancer biology and neuroprotection. Research indicates that OCM-1 may have a significant role in modulating the tumor microenvironment and influencing the immune response, making it a potential biomarker for cancer progression. Furthermore, its ability to bind calcium suggests it could play a critical role in cellular signaling pathways. Recent studies have focused on the recombinant expression of OCM-1 to better understand its functional mechanisms and potential therapeutic applications. By producing this protein in a controlled laboratory setting, researchers aim to delineate its interactions with other proteins and its effects on various cellular processes. Understanding the role of OCM-1 in both normal physiology and disease states is crucial for exploring its potential as a therapeutic target or biomarker in cancer and other related diseases. As such, OCM-1 represents an exciting avenue for future research, with implications spanning from basic molecular biology to clinical applications in oncology and regenerative medicine.
